Showing 1-2 of about 2 articles.
Vasomune Therapeutics
Toronto, ON, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced today Douglas ...
AnGes, Inc.
Tokyo, Japan and Toronto, Ontario, July 31, 2018 (GLOBE NEWSWIRE) -- Vasomune Therapeutics (“Vasomune”), a Toronto-based spin-out from Sunnybrook Research Institute and MaRS Innovation, and AnGes, ...
Showing 1-2 of about 2 articles.